ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of GBP 1.00 billion. The enterprise value is 971.82 million.

Market Cap	1.00B
Enterprise Value	971.82M

Important Dates

The next estimated earnings date is Wednesday, February 5, 2025.

Earnings Date	Feb 5, 2025
Ex-Dividend Date	Oct 11, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	17.34M

Valuation Ratios

The trailing PE ratio is 64.86.

PE Ratio	64.86
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	18.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 47.96, with an EV/FCF ratio of 79.11.

EV / Earnings	62.72
EV / Sales	21.02
EV / EBITDA	47.96
EV / EBIT	50.75
EV / FCF	79.11

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.01.

Current Ratio	4.97
Quick Ratio	3.71
Debt / Equity	0.01
Debt / EBITDA	0.02
Debt / FCF	0.04
Interest Coverage	923.32

Financial Efficiency

Return on equity (ROE) is 24.82% and return on invested capital (ROIC) is 19.03%.

Return on Equity (ROE)	24.82%
Return on Assets (ROA)	15.82%
Return on Capital (ROIC)	19.03%
Revenue Per Employee	266,486
Profits Per Employee	89,043
Employee Count	174
Asset Turnover	0.61
Inventory Turnover	0.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+40.15%
50-Day Moving Average	486.63
200-Day Moving Average	395.55
Relative Strength Index (RSI)	54.81
Average Volume (20 Days)	610

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of GBP 46.37 million and earned 15.49 million in profits. Earnings per share was 0.89.

Revenue	46.37M
Gross Profit	41.79M
Operating Income	19.21M
Pretax Income	20.08M
Net Income	15.49M
EBITDA	20.32M
EBIT	19.21M
Earnings Per Share (EPS)	0.89

Full Income Statement

Balance Sheet

The company has 33.67 million in cash and 472,360 in debt, giving a net cash position of 33.19 million.

Cash & Cash Equivalents	33.67M
Total Debt	472,360
Net Cash	33.19M
Net Cash Per Share	n/a
Equity (Book Value)	64.27M
Book Value Per Share	3.69
Working Capital	44.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.67 million and capital expenditures -2.38 million, giving a free cash flow of 12.28 million.

Operating Cash Flow	14.67M
Capital Expenditures	-2.38M
Free Cash Flow	12.28M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 90.13%, with operating and profit margins of 41.43% and 33.41%.

Gross Margin	90.13%
Operating Margin	41.43%
Pretax Margin	43.29%
Profit Margin	33.41%
EBITDA Margin	43.83%
EBIT Margin	41.43%
FCF Margin	26.49%

Dividends & Yields

This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.45
Dividend Yield	0.09%
Dividend Growth (YoY)	-35.48%
Years of Dividend Growth	n/a
Payout Ratio	76.62%
Buyback Yield	n/a
Shareholder Yield	0.09%
Earnings Yield	1.54%
FCF Yield	1.22%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ChemoMetec has an Altman Z-Score of 38.72.

Altman Z-Score	38.72
Piotroski F-Score	n/a